Pharmaceuticals Stocks

208 companies · NSE & BSE · Updated daily

About the Pharmaceuticals Sector

The Indian pharmaceutical sector, a consistent performer, is showing signs of renewed strength. Driven by domestic demand, export opportunities, and a focus on specialty generics, many Indian pharma players are poised for growth. Bull Run's analysis highlights stocks exhibiting robust financial health and promising valuations.

Indian pharmaceutical companies are increasingly leveraging their R&D capabilities and manufacturing prowess to capture global market share, particularly in regulated markets like the US. Favorable regulatory pathways, such as USFDA approvals and ANDA filings, are critical indicators of future revenue streams. While the sector grapples with pricing pressures in certain segments, a strategic shift towards complex generics and contract development and manufacturing (CDMO) services is proving effective. Diversification across therapeutic areas and geographies mitigates risk and enhances long-term sustainability.

What to Watch

Monitor USFDA inspection outcomes and the pace of new product approvals. Keep an eye on the evolving regulatory landscape in key export markets and the competitive intensity in the domestic formulations business. Increasing R&D spends and CDMO order books are positive signals for future growth.

Related Research

Compare Pharma Stocks →High ROE Pharma Stocks →Nifty Pharma Index →Pharma Sector Analysis →Screen Pharmaceuticals →

Frequently Asked Questions

What are the key drivers for the Indian Pharma sector's bull run?

Key drivers include strong domestic demand, increasing export opportunities in regulated markets, government initiatives like PLI schemes, and a growing focus on specialty and complex generics. The CDMO segment is also a significant growth catalyst.

How important are USFDA approvals for Indian pharma stocks?

USFDA approvals are crucial as they grant access to the lucrative US market, which is the largest pharmaceutical market globally. Successful approvals and inspections indicate product quality and compliance, directly impacting revenue potential and investor confidence.

What is the role of R&D and innovation in this sector?

R&D and innovation are vital for developing differentiated products, complex generics, and biosimilars. Companies investing significantly in R&D are better positioned to command higher margins and gain a competitive edge, especially in innovation-driven segments.

How does the Bull Run score assess pharma stocks?

The Bull Run score evaluates pharma stocks based on financial health (ROE, debt-to-equity), valuation metrics (P/E), and growth prospects. It aims to identify fundamentally sound companies trading at reasonable valuations within the sector.

Pharmaceuticals Stocks — Page 5 of 7

#	Company	Symbol	Price	Change	Market Cap
121	Sat Kartar Financials P/E Results	SATKARTAR	₹143.30	-1.07%	₹0.2K Cr
122	Coral Laboratories Ltd Financials P/E Results	CORALAB	₹570.90	+0.95%	₹0.2K Cr
123	Oxygenta Pharmaceutical Ltd Financials P/E Results	OXYGENTAPH	₹52.76	-1.27%	₹0.2K Cr
124	Brooks Laboratories Limited Financials P/E Results	BROOKS	₹61.02	-3.28%	₹0.2K Cr
125	Natural Capsules Limited Financials P/E Results	NATCAPSUQ	₹172.54	-4.37%	₹0.2K Cr
126	ACCRETION PHARMA LIMITED Financials P/E Results	ACCPL	₹208.80	-4.66%	₹0.2K Cr
127	Parnax Lab Limited Financials P/E Results	PARNAXLAB	₹120.26	-2.91%	₹0.2K Cr
128	Achyut Healthcare Ltd Financials P/E Results	ACHYUT	₹6.90	+1.17%	₹0.2K Cr
129	Bal Pharma Limited Financials P/E Results	BALPHARMA	₹101.33	-5.69%	₹0.2K Cr
130	Kimia Biosciences Ltd Financials P/E Results	KIMIABL	₹28.81	+1.44%	₹0.2K Cr
131	Par Drugs And Chemicals Limited Financials P/E Results	PAR	₹127.19	-5.00%	₹0.2K Cr
132	Auro Laboratories Limited Financials P/E Results	AUROLAB	₹247.90	+1.93%	₹0.2K Cr
133	QUEST LABORATORIES Financials P/E Results	QUESTLAB	₹78.00	+1.30%	₹0.1K Cr
134	Syschem India Ltd Financials P/E Results	SYSCHEM	₹29.40	-0.64%	₹0.1K Cr
135	Gujarat Inject Kerala Ltd Financials P/E Results	GUJINJEC	₹9.79	-4.21%	₹0.1K Cr
136	Panchsheel Organics Ltd Financials P/E Results	PANCHSHEEL	₹105.45	-1.59%	₹0.1K Cr
137	Smruthi Organics Ltd Financials P/E Results	SMRUTHIORG	₹165.05	+0.00%	₹0.1K Cr
138	BALAXI PHARMACEUTICALS LIMITED Financials P/E Results	BALAXI	₹23.33	+0.91%	₹0.1K Cr
139	Alpa Laboratories Limited Financials P/E Results	ALPA	₹61.12	+1.21%	₹0.1K Cr
140	Lactose India Ltd Financials P/E Results	LACTOSE	₹99.35	+0.30%	₹0.1K Cr
141	Krebs Biochemicals and Industries Limited Financials P/E Results	KREBSBIO	₹55.65	-1.10%	₹0.1K Cr
142	Tyche Industries Ltd Financials P/E Results	TYCHE	₹106.95	-1.29%	₹0.1K Cr
143	Sotac Pharmaceuticals Ltd Financials P/E Results	SOTAC	₹90.05	+0.00%	₹0.1K Cr
144	Concord Drugs Financials P/E Results	538965	₹79.30	-0.21%	₹0.1K Cr
145	Pharmaids Pharmaceuticals Limited Financials P/E Results	PHARMAID	₹29.62	-0.67%	₹0.1K Cr
146	Denis Chem Lab Ltd Financials P/E Results	DENISCHEM	₹70.16	-0.43%	₹0.1K Cr
147	Mercury Labs Financials P/E Results	MERCURYLAB	₹860.00	+0.00%	₹0.1K Cr
148	Attock Petroleum Ltd Financials P/E Results	APL	₹108.80	+1.21%	₹0.1K Cr
149	ZENITH DRUGS LIMIT Financials P/E Results	ZENITHDRUG	₹43.15	-6.40%	₹0.1K Cr
150	Makers Laboratories Limited Financials P/E Results	MAKERSL	₹177.92	+2.39%	₹0.1K Cr

← View All Sectors